How long do kidney transplant recipients live?

As a result, the average life expectancy for a patient on dialysis is generally five years. On the other hand, patients who receive a kidney transplant typically live longer than those who stay on dialysis. A living donor kidney functions, on average, 12 to 20 years, and a deceased donor kidney from 8 to 12 years.

What can kidney transplant patients take for gout?

Prophylactic and treatment options include allopurinol, colchicine, corticosteroids, and, if absolutely necessary, nonsteroidal antiinflammatory drugs.

Can kidney transplant patients take colchicine?

Colchicine is widely employed for the treatment of gout in renal transplant patients where NSAIDs are contra-indicated and allopurinol prophylaxis is often avoided due to concomitant azathioprine immunosuppression.

Can you get gout after a kidney transplant?

Gout is a frequent comorbidity among recipients of kidney transplant [3]. New-onset gout following kidney transplantation (KT) has been observed in 4% to 17% of recipients [3], [4], [5], [6], [7], [8] and the overall prevalence of gout in patients who have undergone renal transplantation is an estimated 13% [9].

Is there a link between gout and kidney failure?

Although gout has been linked to worse outcomes among kidney recipients in the literature, there are presently no publications on gout severity among patients with KT in comparison to other patients with gout.

Can a person with hyperuricemia never develop gout?

Yet many people with hyperuricemia never develop gout, and even when they do, they often have had high levels of uric acid in their blood for years without any symptoms.

How does gout affect your risk of heart attack?

Gout has been associated with an increased risk for heart attacks. High uric acid levels may affect the smoothness of the inside of blood vessels and make platelets in the blood “stickier,” so blood clots are more likely to form.

https://www.youtube.com/watch?v=d1_U2jcgBNE